MeCP2, the protein impaired in most cases of Rett syndrome, controls the production of alpha-synuclein, a protein implicated in…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
The Rett Syndrome Research Trust (RSRT) has partnered with Vivalink to use its Multi-Vital ECG wearable patch…
New research supports how the lack of Mecp2 protein impairs the function of healthy nerve cells in a mouse study…
A lack of MECP2 protein, the chief underlying cause of Rett syndrome, prevented precursor cells from transforming into fully…
The International Rett Syndrome Foundation (IRSF) has launched the My Rett Ally app as a digital tool to help…
The first patient has been dosed with TSHA-102, an investigational gene therapy by Taysha Gene Therapies, to treat…
Daybue (trofinetide) is easing the neurobehavioral symptoms of Rett syndrome with acceptable safety in girls ages 2 to…
Mice in Rett syndrome models showed a loss of brain volume before disease symptoms were evident, with brain shrinkage…
A comprehensive 3D gait analysis found patients with Rett syndrome, ages 5-18, had a slow walking speed and shorter…
Nerve cells derived from Rett syndrome patients showed alterations in structure, function, and network connectivity that depend on the…